{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:47:22Z","timestamp":1792511242273,"version":"4.5.0"},"reference-count":154,"publisher":"American Chemical Society (ACS)","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Macrophages play a paradoxical role in inflammation and tumor. They can protect the host during acute inflammation but act as the main driver for the chronic inflammation which is a common characteristic of several diseases including rheumatoid arthritis, atherosclerosis, type 2 diabetes, inflammatory bowel disease, and neurodegenerative diseases such as Alzheimer\u2019s disease and Parkinson\u2019s disease. In the tumor microenvironment, macrophages switch their phenotype to the immunosuppressive M2 state that promotes tumor growth, angiogenesis, and metastasis. Emerging nanomaterial platforms are trying to offer transformative solutions by enabling the precise delivery of immunomodulatory drugs directly to disease-site macrophages.<\/jats:p>\n                  <jats:p>This review will provide comprehensive comparative analysis of these emerging nanomaterial designs strategies across two disease paradigms: inflammatory diseases and tumor. The discussion will focus on various strategies which include inhibiting chemokine axis (CCL2-CCR2 axis), selective elimination of macrophages through apoptosis, metabolic reprogramming, biomimetic and apoptotic cell-inspired nanoparticles leveraging natural macrophage clearance pathways to promote M2 polarization in inflammation, and the activation of tumor-associated macrophages via TLR and STING agonist. We highlight the role of nanoparticle surface chemistry, composition, and targeting ligands in achieving the two opposite therapeutic outcomes of these two diseases while maintaining some common design principles including EPR-mediated accumulation at the disease sites and biomimetic modifications. We also mentioned novel next-generation nanoparticle-based platforms that are currently in clinical trials for the treatment of tumor and inflammatory diseases. Finally, we discuss the barriers that limit the clinical translational potential of broad nanoparticles, with particular emphasis on nanoparticle-related immunotoxicity, macrophage heterogeneity, and manufacturing reproducibility of the nanoparticles.<\/jats:p>","DOI":"10.1021\/acsabm.6c01937","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:01:25Z","timestamp":1792508485000},"source":"Crossref","is-referenced-by-count":0,"title":["Nanomaterial Design for Macrophage Reprogramming: Emerging Strategies and Mechanistic Insights for Inflammation and Tumor Therapy"],"prefix":"10.1021","author":[{"given":"Nitish","family":"Giri","sequence":"first","affiliation":[{"name":"Vellore Institute of Technology , , , ,","place":["Vellore, Tamil Nadu, India, 632014"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2138-7913","authenticated-orcid":true,"given":"Atanu","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Vellore Institute of Technology , , , ,","place":["Vellore, Tamil Nadu, India, 632014"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"issue":"1","key":"2026102011011735000_cit1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in Immunoregulation and Therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"2026102011011735000_cit2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/imr.13214","article-title":"The Role of Efferocytosis-fueled Macrophage Metabolism in the Resolution of Inflammation","volume":"319","author":"Schilperoort","year":"2023","journal-title":"Immunol. Rev."},{"key":"2026102011011735000_cit3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1275203","article-title":"Efferocytosis by Macrophages in Physiological and Pathological Conditions: Regulatory Pathways and Molecular Mechanisms","volume":"15","author":"Sheng","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"2026102011011735000_cit4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.immuni.2016.02.024","article-title":"Tissue-Resident Macrophage Ontogeny and Homeostasis","volume":"44","author":"Ginhoux","year":"2016","journal-title":"Immunity"},{"key":"2026102011011735000_cit5","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2025.104982","article-title":"Revisiting TAM Polarization: Beyond M1- and M2-Type TAM toward Clinical Precision in Macrophage-Targeted Therapy","volume":"143","author":"Wang","year":"2025","journal-title":"Exp. Mol. Pathol."},{"issue":"1","key":"2026102011011735000_cit6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41419-025-07610-3","article-title":"The Transition between M1 and M2 Macrophage Phenotypes Is Associated with the Disease Status Following CD19 CAR-T Therapy for B Cell Lymphoma\/Leukemia","volume":"16","author":"Zhao","year":"2025","journal-title":"Cell Death Dis."},{"issue":"5","key":"2026102011011735000_cit7","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.349","article-title":"Signaling Pathways in Macrophages: Molecular Mechanisms and Therapeutic Targets","volume":"4","author":"Li","year":"2023","journal-title":"MedComm (Beijing)"},{"issue":"3","key":"2026102011011735000_cit8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1568010054022024","article-title":"Macrophages in Inflammation","volume":"4","author":"Fujiwara","year":"2005","journal-title":"Curr. Drug Target-Inflamm. Allergy"},{"issue":"1","key":"2026102011011735000_cit9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","article-title":"Targeting Macrophages in Cancer Immunotherapy","volume":"6","author":"Duan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"11","key":"2026102011011735000_cit10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as Tools and Targets in Cancer Therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"2026102011011735000_cit11","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.matt.2022.03.005","article-title":"Precision Design of Engineered Nanomaterials to Guide Immune Systems for Disease Treatment","volume":"5","author":"Li","year":"2022","journal-title":"Matter"},{"issue":"1","key":"2026102011011735000_cit12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12951-022-01343-7","article-title":"The Interaction between Nanoparticles and Immune System: Application in the Treatment of Inflammatory Diseases","volume":"20","author":"Liu","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"13","key":"2026102011011735000_cit13","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1073\/pnas.0600997103","article-title":"Role of Target Geometry in Phagocytosis","volume":"103","author":"Champion","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"2026102011011735000_cit14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s12274-020-2655-6","article-title":"The Enhanced Permeability and Retention Effect Based Nanomedicine at the Site of Injury","volume":"13","author":"Liu","year":"2020","journal-title":"Nano Res."},{"key":"2026102011011735000_cit15","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S47129","article-title":"Nanomedicine for Drug Targeting: Strategies beyond the Enhanced Permeability and Retention Effect","volume":"9","author":"Greish","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"2026102011011735000_cit16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1039\/C7BM00747G","article-title":"Zwitterionic Stealth Peptide-Protected Gold Nanoparticles Enable Long Circulation without the Accelerated Blood Clearance Phenomenon","volume":"6","author":"Zhao","year":"2018","journal-title":"Biomater. Sci."},{"key":"2026102011011735000_cit17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.actbio.2017.10.034","article-title":"Surface-Adaptive Zwitterionic Nanoparticles for Prolonged Blood Circulation Time and Enhanced Cellular Uptake in Tumor Cells","volume":"65","author":"Ou","year":"2018","journal-title":"Acta Biomater."},{"issue":"12","key":"2026102011011735000_cit18","doi-asserted-by":"publisher","first-page":"17932","DOI":"10.1021\/acsami.4c19160","article-title":"Reprogramming Macrophage Phenotype Using a Reactive Oxygen Species-Responsive Liposome Delivery System for Inflammation Microenvironment Remodeling and Osteoarthritis Treatment","volume":"17","author":"Lai","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026102011011735000_cit19","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2021.102506","article-title":"Targeting Circulating Monocytes with CCL2-Loaded Liposomes Armed with an Oncolytic Adenovirus","volume":"40","author":"Iscaro","year":"2022","journal-title":"Nanomedicine"},{"issue":"10","key":"2026102011011735000_cit20","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202305659","article-title":"Engineered Macrophage Membrane-Coated Nanoparticles with Enhanced CCR2 Expression Promote Spinal Cord Injury Repair by Suppressing Neuroinflammation and Neuronal Death","volume":"20","author":"Gu","year":"2024","journal-title":"Small"},{"key":"2026102011011735000_cit21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.actbio.2024.08.025","article-title":"Targeting Cardiac Resident CCR2+ Macrophage-Secreted MCP-1 to Attenuate Inflammation after Myocardial Infarction","volume":"211","author":"Wen","year":"2026","journal-title":"Acta Biomater."},{"issue":"1","key":"2026102011011735000_cit22","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1021\/acsnano.0c08185","article-title":"CC Chemokine Receptor 2-Targeting Copper Nanoparticles for Positron Emission Tomography-Guided Delivery of Gemcitabine for Pancreatic Ductal Adenocarcinoma","volume":"15","author":"Zhang","year":"2021","journal-title":"ACS Nano"},{"issue":"47","key":"2026102011011735000_cit23","doi-asserted-by":"publisher","first-page":"64178","DOI":"10.1021\/acsami.5c16272","article-title":"Phenylated Lipid Nanoparticles Specifically Targeting the Ankle Joint for Delivery of MiR-709-z in the Treatment of Rheumatoid Arthritis","volume":"17","author":"Chen","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026102011011735000_cit24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IJN.S573349","article-title":"Biomimetic Nanoplatform Based on Macrophage Membrane-Coated Fe3O4 Nanoparticles for Synergistic Ferroptosis and Sonodynamic Therapy of Lung Cancer","volume":"21","author":"Zhang","year":"2026","journal-title":"Int. J. Nanomed."},{"issue":"26","key":"2026102011011735000_cit25","doi-asserted-by":"publisher","first-page":"30930","DOI":"10.1021\/acsami.1c03600","article-title":"Near-Infrared Light-Driven Multifunctional Tubular Micromotors for Treatment of Atherosclerosis","volume":"13","author":"Li","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026102011011735000_cit26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120390","article-title":"Targeted Silver Nanoparticles for Rheumatoid Arthritis Therapy via Macrophage Apoptosis and Re-Polarization","volume":"264","author":"Yang","year":"2021","journal-title":"Biomaterials"},{"issue":"14","key":"2026102011011735000_cit27","doi-asserted-by":"publisher","first-page":"6860","DOI":"10.7150\/thno.57511","article-title":"Magnetism-Mediated Targeting Hyperthermia-Immunotherapy in \u201cCold\u201d Tumor with CSF1R Inhibitor","volume":"11","author":"Fang","year":"2021","journal-title":"Theranostics"},{"issue":"9","key":"2026102011011735000_cit28","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1021\/acs.nanolett.4c00003","article-title":"Intracellular Magnetic Hyperthermia Enables Concurrent Down-Regulation of CD47 and SIRP\u03b1 To Potentiate Antitumor Immunity","volume":"24","author":"Wang","year":"2024","journal-title":"Nano Lett."},{"key":"2026102011011735000_cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.126073","article-title":"Targeting CCL2 Silencing Using Polymer-Lipid Hybrid Nanoparticles to Reduce Cytokine Storm and Inflammation in Severe COVID-19","volume":"683","author":"Athaydes Seabra Ferreira","year":"2025","journal-title":"Int. J. Pharm."},{"key":"2026102011011735000_cit30","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2026.116105","article-title":"Nanodiscs for Drug Delivery","volume":"268","author":"Ravula","year":"2026","journal-title":"Colloids Surf., B"},{"issue":"1","key":"2026102011011735000_cit31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1021\/acs.bioconjchem.6b00569","article-title":"Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles","volume":"28","author":"Kroll","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"2026102011011735000_cit32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jconrel.2025.02.005","article-title":"Metabolic Reprogramming of Macrophages by a Nano-Sized Opsonization Strategy to Restore M1\/M2 Balance for Osteoarthritis Therapy","volume":"380","author":"Chen","year":"2025","journal-title":"J. Controlled Release"},{"issue":"6","key":"2026102011011735000_cit33","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s41401-025-01727-z","article-title":"CSF1R Inhibitor C19 for Glioma Immunotherapy Enabled by Brain-Targeting Liposomal Delivery","volume":"47","author":"Song","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"2026102011011735000_cit34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014The First FDA-Approved Nano-Drug: Lessons Learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Controlled Release"},{"issue":"1","key":"2026102011011735000_cit35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/515085","article-title":"U. S. Food and Drug Administration Approval of AmBisome (Liposomal Amphotericin B) for Treatment of Visceral Leishmaniasis","volume":"28","author":"Meyerhoff","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"2026102011011735000_cit36","author":"U.S. Food and Drug Administration","year":"2015"},{"issue":"9","key":"2026102011011735000_cit37","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1158\/1078-0432.CCR-18-2990","article-title":"FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia","volume":"25","author":"Krauss","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"2026102011011735000_cit38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jconrel.2019.05.003","article-title":"Injectable, Long-Acting PLGA Formulations: Analyzing PLGA and Understanding Microparticle Formation","volume":"304","author":"Park","year":"2019","journal-title":"J. Controlled Release"},{"issue":"1","key":"2026102011011735000_cit39","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10600","article-title":"PEGylated Therapeutics in the Clinic","volume":"9","author":"Gao","year":"2024","journal-title":"Bioeng. Transl. Med."},{"issue":"1","key":"2026102011011735000_cit40","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-physiol-022516-034348","article-title":"Macrophages and the Recovery from Acute and Chronic Inflammation","volume":"79","author":"Hamidzadeh","year":"2017","journal-title":"Annu. Rev. Physiol."},{"issue":"10","key":"2026102011011735000_cit41","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/cmdc.202000996","article-title":"The Role of Chronic Inflammation in Various Diseases and Anti-inflammatory Therapies Containing Natural Products","volume":"16","author":"Wang","year":"2021","journal-title":"ChemMedChem"},{"issue":"12","key":"2026102011011735000_cit42","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic Inflammation in the Etiology of Disease across the Life Span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"issue":"2","key":"2026102011011735000_cit43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1515\/mr-2022-0047","article-title":"Progress in Nanoparticle-Based Regulation of Immune Cells","volume":"3","author":"Fan","year":"2023","journal-title":"Med. Rev."},{"issue":"11","key":"2026102011011735000_cit44","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte Recruitment during Infection and Inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"2026102011011735000_cit45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.157660","article-title":"CCL2-Scavenging Nanodecoy Hydrogel Multi-Step Remodel Monocytes Recruitment and Macrophages Polarization for Periodontitis Treatment","volume":"501","author":"Wang","year":"2024","journal-title":"Chem. Eng. J."},{"issue":"2","key":"2026102011011735000_cit46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11883-020-0826-2","article-title":"Nucleic Acid\u2013Based Therapies for Atherosclerosis","volume":"22","author":"M\u00e4kinen","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"issue":"8","key":"2026102011011735000_cit47","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1096\/fj.201701536R","article-title":"Endothelial MicroRNAs Regulating the NF-\u03baB Pathway and Cell Adhesion Molecules during Inflammation","volume":"32","author":"Zhong","year":"2018","journal-title":"FASEB J."},{"issue":"8","key":"2026102011011735000_cit48","doi-asserted-by":"publisher","first-page":"7721","DOI":"10.1021\/acsnano.3c00288","article-title":"Neutrophil-Membrane-Coated Biomineralized Metal\u2013Organic Framework Nanoparticles for Atherosclerosis Treatment by Targeting Gene Silencing","volume":"17","author":"Liu","year":"2023","journal-title":"ACS Nano"},{"issue":"8","key":"2026102011011735000_cit49","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.4103\/NRR.NRR-D-24-00119","article-title":"C Motif Chemokine Ligand 2\/C\u2013C Motif Chemokine Receptor 2 Pathway as a Therapeutic Target and Regulatory Mechanism for Spinal Cord Injury","volume":"20","author":"Wang","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"1","key":"2026102011011735000_cit50","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41419-026-08431-8","article-title":"Modulation of Immune Cells and Metabolic Reprogramming in Efferocytosis","volume":"17","author":"Oliveira","year":"2026","journal-title":"Cell Death Dis."},{"issue":"1","key":"2026102011011735000_cit51","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1038\/s41467-021-22454-z","article-title":"Targeted Apoptosis of Macrophages and Osteoclasts in Arthritic Joints Is Effective against Advanced Inflammatory Arthritis","volume":"12","author":"Deng","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"2026102011011735000_cit52","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41419-024-07166-8","article-title":"Inflammation in Atherosclerosis: Pathophysiology and Mechanisms","volume":"15","author":"Ajoolabady","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"2026102011011735000_cit53","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12951-025-03501-z","article-title":"Polypyrrole-Ferric Phosphate-Methotrexate Nanoparticles Enhance Apoptosis\/Ferroptosis of M1 Macrophages via Autophagy Blockage for Rheumatoid Arthritis Treatment","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"5","key":"2026102011011735000_cit54","doi-asserted-by":"publisher","first-page":"520","DOI":"10.7150\/ijbs.8879","article-title":"Macrophage Polarization in Inflammatory Diseases","volume":"10","author":"Liu","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"2026102011011735000_cit55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01462","article-title":"The Metabolic Signature of Macrophage Responses","volume":"10","author":"Viola","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"2026102011011735000_cit56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-020-00251-y","article-title":"Metabolic Reprogramming in Macrophage Responses","volume":"9","author":"Liu","year":"2021","journal-title":"Biomark. Res."},{"key":"2026102011011735000_cit57","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1264842","article-title":"Novel Potential Pharmacological Applications of Dimethyl Fumarate\u2014an Overview and Update","volume":"14","author":"Bresciani","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"51","key":"2026102011011735000_cit58","doi-asserted-by":"publisher","first-page":"69180","DOI":"10.1021\/acsami.5c19664","article-title":"Mitochondrial-Targeting Drug-Loaded Nanoparticles Reprogram Macrophage Metabolism via ROS\/NO Co-Elimination for Diabetic Wound Healing","volume":"17","author":"Zhou","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"10","key":"2026102011011735000_cit59","doi-asserted-by":"publisher","first-page":"8350","DOI":"10.1021\/acsnano.5c18044","article-title":"Reprogramming Lesional Macrophage Homeostasis via Interferon Regulatory Factor 5 Targeted SiRNA Nanoimmunotherapy for Atherosclerosis","volume":"20","author":"He","year":"2026","journal-title":"ACS Nano"},{"issue":"1","key":"2026102011011735000_cit60","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbrc.2014.09.077","article-title":"Acute Downregulation of MiR-155 at Wound Sites Leads to a Reduced Fibrosis through Attenuating Inflammatory Response","volume":"453","author":"Yang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2026102011011735000_cit61","doi-asserted-by":"publisher","DOI":"10.1101\/2025.10.16.682055","article-title":"Scaffold-Mediated MiRNA-155 Inhibition Promotes Regenerative Macrophage Polarisation Leading to Anti-Inflammatory, Angiogenic and Neurogenic Responses for Wound Healing","author":"Palomeque Ch\u00e1vez","year":"2025","journal-title":"bioRxiv"},{"issue":"3","key":"2026102011011735000_cit62","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1021\/acsmaterialslett.5c01506","article-title":"Curcumin-Loaded Biohybrid Nanoparticles Modulating Inflammation and Reducing Lipid Accumulation in Atherosclerotic Plaques for Atherosclerosis Treatment","volume":"8","author":"Ji","year":"2026","journal-title":"ACS Mater. Lett."},{"issue":"1","key":"2026102011011735000_cit63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.apsb.2017.12.002","article-title":"Biomimetic Nanoparticles for Inflammation Targeting","volume":"8","author":"Jin","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"2026102011011735000_cit64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12951-025-03921-x","article-title":"Macrophage Membrane-Coated Nanoparticles in Inflammatory Diseases: From Bioinspired Design to Translational Potential","volume":"24","author":"Hou","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"2026102011011735000_cit65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s11658-020-00214-z","article-title":"The Role of Phosphatidylserine Recognition Receptors in Multiple Biological Functions","volume":"25","author":"Naeini","year":"2020","journal-title":"Cell. Mol. Biol. Lett."},{"key":"2026102011011735000_cit66","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00627","article-title":"Cell Membrane-Based Biomimetic Nanoparticles and the Immune System: Immunomodulatory Interactions to Therapeutic Applications","volume":"8","author":"Sushnitha","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"5","key":"2026102011011735000_cit67","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1073\/pnas.1015623108","article-title":"Ben; Amsalem, Y.; Feinberg, M. S.; Leor, J.; Cohen, S. Modulation of Cardiac Macrophages by Phosphatidylserine-Presenting Liposomes Improves Infarct Repair","volume":"108","author":"Harel-Adar","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"2026102011011735000_cit68","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/jcbfm.2009.95","article-title":"Phosphatidylserine-Containing Liposomes Promote Maximal Survival of Retinal Neurons after Ischemic Injury","volume":"29","author":"Dvoriantchikova","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"2026102011011735000_cit69","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.actbio.2021.07.002","article-title":"Soft Apoptotic-Cell-Inspired Nanoparticles Persistently Bind to Macrophage Membranes and Promote Anti-Inflammatory and pro-Healing Effects","volume":"131","author":"Zhang","year":"2021","journal-title":"Acta Biomater."},{"issue":"10","key":"2026102011011735000_cit70","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1002\/cam4.5698","article-title":"Role of Tumor Microenvironment in Cancer Progression and Therapeutic Strategy","volume":"12","author":"Wang","year":"2023","journal-title":"Cancer Med."},{"issue":"8","key":"2026102011011735000_cit71","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The Complex Role of Tumor-Infiltrating Macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat. Immunol."},{"issue":"5","key":"2026102011011735000_cit72","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s10238-022-00888-z","article-title":"Role of Chemokines in the Crosstalk between Tumor and Tumor-Associated Macrophages","volume":"23","author":"Qin","year":"2022","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"2026102011011735000_cit73","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s40001-024-01711-z","article-title":"The Paradoxical Role of Cytokines and Chemokines at the Tumor Microenvironment: A Comprehensive Review","volume":"29","author":"Abdul-Rahman","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"2026102011011735000_cit74","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12943-022-01645-2","article-title":"The Hypoxia-Driven Crosstalk between Tumor and Tumor-Associated Macrophages: Mechanisms and Clinical Treatment Strategies","volume":"21","author":"Bai","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"2026102011011735000_cit75","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12672-024-01256-x","article-title":"The Complex Role of Macrophages in Pancreatic Cancer Tumor Microenvironment: A Review on Cancer Progression and Potential Therapeutic Targets","volume":"15","author":"Lorestani","year":"2024","journal-title":"Discover Oncol."},{"issue":"1","key":"2026102011011735000_cit76","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12964-020-0527-z","article-title":"Role of STAT3 Signaling Pathway in Breast Cancer","volume":"18","author":"Ma","year":"2020","journal-title":"Cell Commun. Signal."},{"issue":"3","key":"2026102011011735000_cit77","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10585-019-09966-1","article-title":"The Extracellular Matrix in Tumor Progression and Metastasis","volume":"36","author":"Eble","year":"2019","journal-title":"Clin. Exp. Metastasis"},{"key":"2026102011011735000_cit78","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115318","article-title":"The Role of CCL2\/CCR2 Axis in Cancer and Inflammation: The next Frontier in Nanomedicine","volume":"209","author":"Pozzi","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"2026102011011735000_cit79","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13115","article-title":"Role of the CCL2-CCR2 Signalling Axis in Cancer: Mechanisms and Therapeutic Targeting","volume":"54","author":"Xu","year":"2021","journal-title":"Cell Prolif."},{"issue":"8","key":"2026102011011735000_cit80","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1021\/mp400714z","article-title":"Cationic Lipid-Assisted Polymeric Nanoparticle Mediated GATA2 SiRNA Delivery for Synthetic Lethal Therapy of KRAS Mutant Non-Small-Cell Lung Carcinoma","volume":"11","author":"Shen","year":"2014","journal-title":"Mol. Pharm."},{"issue":"31","key":"2026102011011735000_cit81","doi-asserted-by":"publisher","first-page":"49349","DOI":"10.18632\/oncotarget.9885","article-title":"Targeted Gene Silencing of CCL2 Inhibits Triple Negative Breast Cancer Progression by Blocking Cancer Stem Cell Renewal and M2 Macrophage Recruitment","volume":"7","author":"Fang","year":"2016","journal-title":"Oncotarget"},{"issue":"23","key":"2026102011011735000_cit82","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202007603","article-title":"MRNA Delivery of a Bispecific Single-Domain Antibody to Polarize Tumor-Associated Macrophages and Synergize Immunotherapy against Liver Malignancies","volume":"33","author":"Wang","year":"2021","journal-title":"Adv. Mater."},{"key":"2026102011011735000_cit83","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mattod.2022.11.008","article-title":"Overcoming Pancreatic Cancer Immune Resistance by Codelivery of CCR2 Antagonist Using a STING-Activating Gemcitabine-Based Nanocarrier","volume":"62","author":"Wan","year":"2023","journal-title":"Mater. Today"},{"issue":"37","key":"2026102011011735000_cit84","doi-asserted-by":"publisher","first-page":"31124","DOI":"10.1021\/acsami.8b11645","article-title":"C\u2013C Chemokine Ligand 2 (CCL2) Recruits Macrophage-Membrane-Camouflaged Hollow Bismuth Selenide Nanoparticles To Facilitate Photothermal Sensitivity and Inhibit Lung Metastasis of Breast Cancer","volume":"10","author":"Zhao","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026102011011735000_cit85","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2026.111131","article-title":"M-CSF Regulates Macrophage Proliferation, Survival, and Anti-Inflammatory Responses in Largemouth Bass (Micropterus Salmoides)","volume":"170","author":"Zhao","year":"2026","journal-title":"Fish Shellfish Immunol."},{"issue":"1","key":"2026102011011735000_cit86","doi-asserted-by":"publisher","DOI":"10.1155\/jimr\/6287638","article-title":"The Research Progress of Tumor-Associated Macrophages in Prostate Cancer","volume":"2026","author":"Shen","year":"2026","journal-title":"J. Immunol. Res."},{"key":"2026102011011735000_cit87","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2147\/DDDT.S253232","article-title":"Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development","volume":"14","author":"Benner","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"issue":"2","key":"2026102011011735000_cit88","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10205","article-title":"Targeted Systemic Dendrimer Delivery of CSF-1R Inhibitor to Tumor-Associated Macrophages Improves Outcomes in Orthotopic Glioblastoma","volume":"6","author":"Liaw","year":"2021","journal-title":"Bioeng. Transl. Med."},{"issue":"8","key":"2026102011011735000_cit89","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.202200168","article-title":"Polymersomes-Mediated Delivery of CSF1R Inhibitor to Tumor Associated Macrophages Promotes M2 to M1-Like Macrophage Repolarization","volume":"22","author":"Rodriguez-Perdigon","year":"2022","journal-title":"Macromol. Biosci."},{"key":"2026102011011735000_cit90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08982104.2026.2664876","article-title":"Nanoliposomes Based Drug Delivery for the Treatment of Various Types of Cancers: Current Trends and Future Perspectives","author":"Barik","year":"2026","journal-title":"J. Liposome Res."},{"issue":"32","key":"2026102011011735000_cit91","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh2413","article-title":"Anti\u2013Phagocytosis-Blocking Repolarization-Resistant Membrane-Fusogenic Liposome (ARMFUL) for Adoptive Cell Immunotherapy","volume":"9","author":"Zheng","year":"2023","journal-title":"Sci. Adv."},{"key":"2026102011011735000_cit92","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119559","article-title":"Dual Inhibition of CSF1R and MAPK Pathways Using Supramolecular Nanoparticles Enhances Macrophage Immunotherapy","volume":"227","author":"Ramesh","year":"2020","journal-title":"Biomaterials"},{"issue":"2","key":"2026102011011735000_cit93","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10549-025-07659-w","article-title":"Targeting \u201cDon\u2019t Eat Me\u201d Signal: Breast Cancer Immunotherapy","volume":"211","author":"Gao","year":"2025","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"2026102011011735000_cit94","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imr.12527","article-title":"The CD47-SIRP\u03b1 Signaling Axis as an Innate Immune Checkpoint in Cancer","volume":"276","author":"Matlung","year":"2017","journal-title":"Immunol. Rev."},{"issue":"10","key":"2026102011011735000_cit95","doi-asserted-by":"publisher","first-page":"8966","DOI":"10.1021\/acsnano.2c08240","article-title":"Nanoparticle-Mediated CD47-SIRP\u03b1 Blockade and Calreticulin Exposure for Improved Cancer Chemo-Immunotherapy","volume":"17","author":"Luo","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"2026102011011735000_cit96","doi-asserted-by":"publisher","first-page":"4909","DOI":"10.1038\/s41467-020-18626-y","article-title":"Hybrid Cellular Membrane Nanovesicles Amplify Macrophage Immune Responses against Cancer Recurrence and Metastasis","volume":"11","author":"Rao","year":"2020","journal-title":"Nat. Commun."},{"issue":"34","key":"2026102011011735000_cit97","doi-asserted-by":"publisher","first-page":"31077","DOI":"10.1021\/acsnano.5c09460","article-title":"Reprogramming Macrophage via an Antigen Phagocytosis-Presentation Nanoenhancer for Improved Cancer Immunotherapy","volume":"19","author":"Liu","year":"2025","journal-title":"ACS Nano"},{"issue":"6","key":"2026102011011735000_cit98","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41416-022-01864-w","article-title":"Challenges in Glioblastoma Immunotherapy: Mechanisms of Resistance and Therapeutic Approaches to Overcome Them","volume":"127","author":"Habashy","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"12","key":"2026102011011735000_cit99","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.7150\/thno.73104","article-title":"Co-Delivery of Phagocytosis Checkpoint and STING Agonist by a Trojan Horse Nanocapsule for Orthotopic Glioma Immunotherapy","volume":"12","author":"Zhou","year":"2022","journal-title":"Theranostics"},{"issue":"12","key":"2026102011011735000_cit100","doi-asserted-by":"publisher","first-page":"7871","DOI":"10.1021\/acsabm.4c00076","article-title":"Macrophage Checkpoint Nanoimmunotherapy Has the Potential to Reduce Malignant Progression in Bioengineered In Vitro Models of Ovarian Cancer","volume":"7","author":"VandenHeuvel","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"issue":"4","key":"2026102011011735000_cit101","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","article-title":"DAMPs and DAMP-Sensing Receptors in Inflammation and Diseases","volume":"57","author":"Ma","year":"2024","journal-title":"Immunity"},{"key":"2026102011011735000_cit102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"2026102011011735000_cit103","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/kjm2.12405","article-title":"Macrophages as a \u201cWeapon\u201d in Anticancer Cellular Immunotherapy","volume":"37","author":"Aminin","year":"2021","journal-title":"Kaohsiung J. Med. Sci."},{"key":"2026102011011735000_cit104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1049340","article-title":"Toll-like Receptor-Targeted Anti-Tumor Therapies: Advances and Challenges","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"issue":"21","key":"2026102011011735000_cit105","doi-asserted-by":"publisher","first-page":"24442","DOI":"10.1021\/acsami.1c01453","article-title":"Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages","volume":"13","author":"Zhang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"2026102011011735000_cit106","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.18632\/oncotarget.23376","article-title":"Betulinic Acid Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Models","volume":"9","author":"Zeng","year":"2018","journal-title":"Oncotarget"},{"issue":"13","key":"2026102011011735000_cit107","doi-asserted-by":"publisher","first-page":"12920","DOI":"10.1021\/acsnano.4c16671","article-title":"Polysaccharide Nanoadjuvants Engineered via Phenotype-Specific Nanoprobe-Assisted Phenotypic Screen Reprogram Macrophage Cell Functions for Cancer and Rheumatoid Arthritis Therapy","volume":"19","author":"Mo","year":"2025","journal-title":"ACS Nano"},{"issue":"12","key":"2026102011011735000_cit108","doi-asserted-by":"publisher","first-page":"11567","DOI":"10.1021\/acsnano.3c01645","article-title":"Multivalent Carbohydrate Nanocomposites for Tumor Microenvironment Remodeling to Enhance Antitumor Immunity","volume":"17","author":"Hyun","year":"2023","journal-title":"ACS Nano"},{"key":"2026102011011735000_cit109","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2025.102893","article-title":"Macrophage-Targeted Polysaccharide Nano-Immunomodulators with Spatial- and Time-Programmed Drug Release for Cancer Therapy","volume":"66","author":"Xu","year":"2026","journal-title":"Nano Today"},{"key":"2026102011011735000_cit110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1485546","article-title":"Clinical Applications of STING Agonists in Cancer Immunotherapy: Current Progress and Future Prospects","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"2026102011011735000_cit111","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.actbio.2025.03.054","article-title":"Nano-Delivery of STING Agonists: Unraveling the Potential of Immunotherapy","volume":"197","author":"Zhang","year":"2025","journal-title":"Acta Biomater."},{"issue":"1","key":"2026102011011735000_cit112","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12943-024-02186-6","article-title":"Nanomedicines Harnessing CGAS-STING Pathway: Sparking Immune Revitalization to Transform \u2018Cold\u2019 Tumors into \u2018Hot\u2019 Tumors","volume":"23","author":"Ying","year":"2024","journal-title":"Mol. Cancer"},{"issue":"7","key":"2026102011011735000_cit113","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2025.104412","article-title":"Exploring Nucleotide and Non-Nucleotide CGAS-STING Agonists: Therapeutic Applications and Future Directions in Cancer Immunotherapy","volume":"30","author":"Ghara","year":"2025","journal-title":"Drug Discov. Today"},{"issue":"9","key":"2026102011011735000_cit114","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1021\/acscentsci.4c00579","article-title":"STING-Activating Polymer\u2013Drug Conjugates for Cancer Immunotherapy","volume":"10","author":"Sheehy","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"2026102011011735000_cit115","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.antiviral.2017.10.001","article-title":"A Cell-Based High Throughput Screening Assay for the Discovery of CGAS-STING Pathway Agonists","volume":"147","author":"Liu","year":"2017","journal-title":"Antiviral Res."},{"issue":"2","key":"2026102011011735000_cit116","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/1535-7163.MCT-21-0136","article-title":"STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors","volume":"21","author":"Perera","year":"2022","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"2026102011011735000_cit117","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40364-023-00551-z","article-title":"Nanomaterial-Encapsulated STING Agonists for Immune Modulation in Cancer Therapy","volume":"12","author":"Chen","year":"2024","journal-title":"Biomark. Res."},{"issue":"7","key":"2026102011011735000_cit118","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1021\/acsnano.4c10202","article-title":"A PH-Responsive and Guanidinium-Rich Nanoadjuvant Efficiently Delivers STING Agonist for Cancer Immunotherapy","volume":"19","author":"Lu","year":"2025","journal-title":"ACS Nano"},{"key":"2026102011011735000_cit119","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2025.214632","article-title":"Light-Directed Reprogramming of Tumor-Associated Macrophages via STING Agonist Delivery","volume":"181","author":"Gusliakova","year":"2026","journal-title":"Biomater. Adv."},{"issue":"1","key":"2026102011011735000_cit120","doi-asserted-by":"publisher","first-page":"277","DOI":"10.7150\/thno.101001","article-title":"A STING Agonist Prodrug Reprograms Tumor-Associated Macrophage to Boost Colorectal Cancer Immunotherapy","volume":"15","author":"Deng","year":"2025","journal-title":"Theranostics"},{"issue":"4","key":"2026102011011735000_cit121","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","article-title":"Microglial M1\/M2 Polarization and Metabolic States","volume":"173","author":"Orihuela","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"2026102011011735000_cit122","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1224443","article-title":"Targeting Reactive Oxygen Species and Fat Acid Oxidation for the Modulation of Tumor-Associated Macrophages: A Narrative Review","volume":"14","author":"Teng","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"2026102011011735000_cit123","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/s41401-024-01304-w","article-title":"Targeting Metabolism to Enhance Immunotherapy within Tumor Microenvironment","volume":"45","author":"Liang","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"14","key":"2026102011011735000_cit124","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1039\/D2BM00650B","article-title":"Nanodrug Regulates Lactic Acid Metabolism to Reprogram the Immunosuppressive Tumor Microenvironment for Enhanced Cancer Immunotherapy","volume":"10","author":"Tian","year":"2022","journal-title":"Biomater. Sci."},{"issue":"10","key":"2026102011011735000_cit125","doi-asserted-by":"publisher","first-page":"14164","DOI":"10.1021\/acsnano.0c07071","article-title":"Engineering of Cascade-Responsive Nanoplatform to Inhibit Lactate Efflux for Enhanced Tumor Chemo-Immunotherapy","volume":"14","author":"Li","year":"2020","journal-title":"ACS Nano"},{"key":"2026102011011735000_cit126","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2026.1741800","article-title":"Mitochondrial Metabolism in Cancer Stem Cells (CSCs): Molecular and Diagnostic Implications","volume":"13","author":"PSVV","year":"2026","journal-title":"Front. Mol. Biosci."},{"issue":"38","key":"2026102011011735000_cit127","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403044","article-title":"Surface Molecularly Engineered Mitochondria Conduct Immunophenotype Repolarization of Tumor-Associated Macrophages to Potentiate Cancer Immunotherapy","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv. Sci."},{"issue":"15","key":"2026102011011735000_cit128","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.1021\/acs.nanolett.1c01401","article-title":"Ferroptosis-Strengthened Metabolic and Inflammatory Regulation of Tumor-Associated Macrophages Provokes Potent Tumoricidal Activities","volume":"21","author":"Gu","year":"2021","journal-title":"Nano Lett."},{"issue":"1","key":"2026102011011735000_cit129","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12967-022-03554-w","article-title":"IDO\/Kynurenine Pathway in Cancer: Possible Therapeutic Approaches","volume":"20","author":"Abd El-Fattah","year":"2022","journal-title":"J. Transl. Med."},{"issue":"5","key":"2026102011011735000_cit130","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202405845","article-title":"Tumor Microenvironment-Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"issue":"1","key":"2026102011011735000_cit131","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","article-title":"MTOR Signaling Pathway and MTOR Inhibitors in Cancer: Progress and Challenges","volume":"10","author":"Zou","year":"2020","journal-title":"Cell Biosci."},{"key":"2026102011011735000_cit132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.774103","article-title":"MTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment","volume":"12","author":"Mafi","year":"2022","journal-title":"Front. Immunol."},{"key":"2026102011011735000_cit133","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120187","article-title":"Metabolic Modulation via MTOR Pathway and Anti-Angiogenesis Remodels Tumor Microenvironment Using PD-L1-Targeting Codelivery","volume":"255","author":"Chen","year":"2020","journal-title":"Biomaterials"},{"key":"2026102011011735000_cit134","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2026.103014","article-title":"Biomimetic Cell-Membrane-Coated Metallic Nanoparticles in Cancer Therapy: Design, Functional Mechanisms, and Translational Challenges","volume":"76","author":"Narula","year":"2026","journal-title":"Nanomedicine"},{"issue":"8","key":"2026102011011735000_cit135","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202400012","article-title":"Cell Membrane-Coated Nanoparticles: A New Frontier in Immunomodulation","volume":"4","author":"Desai","year":"2024","journal-title":"Adv. Nanobiomed. Res."},{"issue":"suppl_4","key":"2026102011011735000_cit136","doi-asserted-by":"publisher","first-page":"S312","DOI":"10.1093\/cid\/cir046","article-title":"Strengths and Weaknesses of FDA-Approved\/Cleared Diagnostic Devices for the Molecular Detection of Respiratory Pathogens","volume":"52","author":"Ginocchio","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"2026102011011735000_cit137","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.colsurfb.2018.04.005","article-title":"The Systematic Evaluation of Size-Dependent Toxicity and Multi-Time Biodistribution of Gold Nanoparticles","volume":"167","author":"Li","year":"2018","journal-title":"Colloids Surf., B"},{"issue":"7","key":"2026102011011735000_cit138","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1007\/s11051-010-9911-8","article-title":"Toxicity and Cellular Uptake of Gold Nanoparticles: What We Have Learned so Far?","volume":"12","author":"Alkilany","year":"2010","journal-title":"J. Nanopart. Res."},{"issue":"1","key":"2026102011011735000_cit139","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.taap.2008.12.023","article-title":"Acute Toxicity and Pharmacokinetics of 13 Nm-Sized PEG-Coated Gold Nanoparticles","volume":"236","author":"Cho","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"2026102011011735000_cit140","doi-asserted-by":"publisher","first-page":"590","DOI":"10.2214\/AJR.22.28453","article-title":"Ferumoxytol-Enhanced MRI in Children and Young Adults: State of the Art","volume":"220","author":"Adams","year":"2023","journal-title":"Am. J. Roentgenol."},{"issue":"1","key":"2026102011011735000_cit141","doi-asserted-by":"publisher","first-page":"31383","DOI":"10.1038\/s41598-024-82917-3","article-title":"Iron Oxide Nanoparticles Induce Ferroptosis under Mild Oxidative Stress in Vitro","volume":"14","author":"Luo","year":"2024","journal-title":"Sci. Rep."},{"key":"2026102011011735000_cit142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2020.124050","article-title":"Amorphous Silica Nanoparticles Induce Inflammation via Activation of NLRP3 Inflammasome and HMGB1\/TLR4\/MYD88\/NF-Kb Signaling Pathway in HUVEC Cells","volume":"404","author":"Liu","year":"2021","journal-title":"J. Hazard. Mater."},{"key":"2026102011011735000_cit143","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jconrel.2023.09.001","article-title":"Polyethylenimine (PEI) in Gene Therapy: Current Status and Clinical Applications","volume":"362","author":"Casper","year":"2023","journal-title":"J. Controll. Rel."},{"issue":"38","key":"2026102011011735000_cit144","doi-asserted-by":"publisher","first-page":"45300","DOI":"10.1021\/acsami.1c14082","article-title":"Core Hydrophobicity of Supramolecular Nanoparticles Induces NLRP3 Inflammasome Activation","volume":"13","author":"Nandi","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026102011011735000_cit145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1111123","article-title":"High Aspect Ratio Nanomaterial-Induced Macrophage Polarization Is Mediated by Changes in MiRNA Levels","volume":"14","author":"Erdem","year":"2023","journal-title":"Front. Immunol."},{"key":"2026102011011735000_cit146","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG Antibodies: Properties, Formation, Testing and Role in Adverse Immune Reactions to PEGylated Nano-Biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"2026102011011735000_cit147","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.7150\/thno.30716","article-title":"Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"issue":"7","key":"2026102011011735000_cit148","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj7002","article-title":"Exosome-Mediated Genetic Reprogramming of Tumor-Associated Macrophages by ExoASO-STAT6 Leads to Potent Monotherapy Antitumor Activity","volume":"8","author":"Kamerkar","year":"2022","journal-title":"Sci. Adv."},{"issue":"34","key":"2026102011011735000_cit149","doi-asserted-by":"publisher","first-page":"23757","DOI":"10.1021\/acsnano.4c08811","article-title":"Targeting Tumor-Associated Macrophages with the Immune-Activating Nanomedicine for Achieving Strong Antitumor Activity with Rapid Clearance from the Body","volume":"18","author":"Ota","year":"2024","journal-title":"ACS Nano"},{"issue":"8_Suppl.","key":"2026102011011735000_cit150","doi-asserted-by":"publisher","first-page":"LB245","DOI":"10.1158\/1538-7445.AM2023-LB245","article-title":"Abstract LB245: ONM-501, a Dual-Activating Polyvalent STING Agonist, Enhances Tumor Retention and Demonstrates Favorable Preclinical Safety Profile","volume":"83","author":"Chen","year":"2023","journal-title":"Cancer Res."},{"issue":"31","key":"2026102011011735000_cit151","doi-asserted-by":"publisher","first-page":"11449","DOI":"10.1073\/pnas.1411393111","article-title":"Correlating Animal and Human Phase Ia\/Ib Clinical Data with CALAA-01, a Targeted, Polymer-Based Nanoparticle Containing SiRNA","volume":"111","author":"Zuckerman","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"2026102011011735000_cit152","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20176225","article-title":"Methotrexate Associated to Lipid Core Nanoparticles Improves Cardiac Allograft Vasculopathy and the Inflammatory Profile in a Rabbit Heart Graft Model","volume":"50","author":"Fiorelli","year":"2017","journal-title":"Braz. J. Med. Biol. Res."},{"key":"2026102011011735000_cit153","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jconrel.2021.12.007","article-title":"Intravenous Pegylated Liposomal Prednisolone Outperforms Intramuscular Methylprednisolone in Treating Rheumatoid Arthritis Flares: A Randomized Controlled Clinical Trial","volume":"341","author":"Metselaar","year":"2022","journal-title":"J. Controlled Release"},{"issue":"46","key":"2026102011011735000_cit154","doi-asserted-by":"publisher","first-page":"39805","DOI":"10.1021\/acsnano.5c12658","article-title":"Natural Macrophage Membrane-Coated Nanoparticles as a Multifaceted Sepsis Therapeutic to Sequester Inflammatory and Toxic Mediators","volume":"19","author":"Hoffman","year":"2025","journal-title":"ACS Nano"}],"container-title":["ACS Applied Bio Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsabm.6c01937","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aabmcb\/article-pdf\/doi\/10.1021\/acsabm.6c01937\/68915192\/mt-2026-01937b.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aabmcb\/article-pdf\/doi\/10.1021\/acsabm.6c01937\/68915192\/mt-2026-01937b.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:10:33Z","timestamp":1792509033000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aabmcb\/article\/doi\/10.1021\/acsabm.6c01937\/5454449\/Nanomaterial-Design-for-Macrophage-Reprogramming"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":154,"URL":"https:\/\/doi.org\/10.1021\/acsabm.6c01937","relation":{},"ISSN":["2576-6422"],"issn-type":[{"value":"2576-6422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]}}}